Bachem produces one of the largest amounts of commercially available synthetic peptide active pharmaceutical ingredients (API) in the world.
From the 80 approved peptide API in new chemical entities (NCEs) and generics that are globally available, Bachem commercialized one third of these API.
Our Good Manufacturing Practice (GMP) facilities are located in Switzerland and the United States and are regularly inspected by Swiss medic, the FDA, EMA, and other local regulatory authorities in the world to ensure our operational excellence and quality.
Bachem strives to develop long-term partnerships with customers. The long-lasting experience and capability of manufacture drug substance in large quantities under GMP conditions as well as the strong regulatory background makes Bachem a preferred commercial partner.
peptide api
With more than 50 years of experience in the development, production, and compiling data for Drug Master Files (DMF), we have built a reputation as a reliable GMP manufacturer of NCEs as well as for high-demand generic products.
We have the capacity to produce peptide API from gram scale up to annual quantities of hundreds of kilograms. Bachem’s quality management system covers the entire production process, from starting materials to production, packaging and delivery of the final product.
Commercial NCEs
Our partners trust in our support and guidance for the commercial supply of GMP-manufactured NCEs.
Commercial Generics
Our partners trust in the constant quality of our generic API to manufacture their drug products.
Why choose Bachem?
- Customer centricity & service – At Bachem, we strive to give our customers an all-round positive experience – no matter who they are or where they are located.
- Innovation and technology – Technological leadership and innovative strength have been the cornerstones of our success since the very beginning of our company.
- Operational excellence and quality – Bachem is a leading and successful global player in the business of developing and manufacturing peptides and oligonucleotides.
- People & culture – Our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success.
- Sustainability – We are committed to sustainability by taking responsibility towards our employees, the society, and the environment.
What our customers are saying
Commercial Peptide API news
Somatostatin Analogues Provide Invaluable Therapeutic Options
What are somatostatin and somatostatin analogues?
Meet Bachem: Pascal Hess, Group Leader Generics – Portfolio
Commercial API knowledge
Our Knowledge Center has a wide variety of tools and materials for peptide and oligonucleotide chemistry.
Brochures
Click here >>
Flyers
click here >>
White papers
click here >>
Further topics of interest
Commercial
Generics
Click here >>
GMP
Production
Click here >>
Quality and
Regulatory
Click here >>
Contact us